Spots Global Cancer Trial Database for Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin
Official Title: Short-term Combined Treatment With Liraglutide and Metformin Leads to Significant Weight Loss in Obese Women With Polycystic Ovary Syndrome and Previous Poor Response to Metformin
Study ID: NCT01911468
Study Description
Brief Summary: The purpose of this study was to determine whether combined treatment with liraglutide and metformin is more effective than liraglutide or metformin as monotherapy in the treatment of obese women with polycystic ovary syndrome (PCOS) who had been previously poor responders regarding weight reduction on metformin monotherapy. We anticipated greater changes in body weight in patients on combined treatment than in those on monotherapy with liraglutide or metformin.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University Medical Center Ljubljana, Ljubljana, , Slovenia
Contact Details
Name: Andrej Janez, MD PhD
Affiliation: University Medical Centre Ljubljana
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
